Most recent news
8 April
2016
Firm news
Marcus Sims awarded two prizes from Chartered Institute of Patent Attorneys (CIPA)
Boult Wade Tennant is delighted to share that a trainee patent attorney, Marcus Sims, has recently been awarded prizes from the Chartered Institute of Patent Attorneys (CIPA) in acknowledgement of his outstanding examination results. Marcus is part of the Chemical and Materials Group which is recognised in the industry for their depth of knowledge and...
5 April
2016
Firm news
Tier one UK firm, Boult Wade Tennant, has announced the appointment of Jason Rutt
Tier one UK firm, Boult Wade Tennant, has announced the appointment of Jason Rutt, who has joined the firm’s Biotechnology and Life Sciences Group, as a Patent Attorney. The appointment is not only a reflection of the continuous growth of this group but clearly demonstrates the firm’s commitment to maintain its market-leading position. The biotechnology...
9 March
2016
Firm news
Boult Wade Tennant ranked top tier for Patents in MIP’s IP Stars Handbook
Managing Intellectual Property (MIP) has once again ranked Boult Wade Tennant in the top tier of its 2016 annual survey for patents. MIP’s IP Stars rankings is one of the most authoritative and comprehensive surveys of the IP legal market. They conduct months of extensive research that covers 80 countries; interviewing thousands of intellectual property...
4 February
2016
Firm news
Boult Wade Tennant ranked top tier for Trade Mark in MIP’s IP Stars Handbook
We are delighted to announce that Managing Intellectual Property (MIP) has ranked our trade mark practice in the top tier of its 2016 annual survey. MIP’s IP Stars rankings are based on extensive research among thousands of intellectual property practitioners from around the globe, creating one of the most comprehensive and authoritative surveys of the IP...
26 January
2016
Firm news
Rachel Conroy provides case comment for Pharma und Marke (PuM)
Read Rachel Conroy’s latest article published on the upcoming online blog and magazine Pharma und Marke (PuM). Here she examines the UKIPO’s decision, made late last year, in Glaxo Group Ltd versus Evonik Industries AG (Case O-587/15). This case, tackling the issue of likelihood of confusion, is of particular interest as the Hearing Officer takes...